In late March, Allergan, Inc. (Irvine, CA), received FDA approval for ZYMAR (gatifloxacin ophthalmic solution 0.3%), making the anti-infective the first fourth-generation fluoroquinolone to enter the US market. According to Allergan, ZYMAR has a unique mechanism of action that slows the development of bacterial resistance. Its molecular structure contains an 8-methoxy group that provides enhanced inhibition of DNA gyrase and Topoisomerase IV. ZYMAR is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of bacteria.

?ZYMAR is the natural next step in the battle between antibiotics and bacterial infection,? says Randall J. Olson, MD, of the John A. Moran Eye Center in Salt Lake City. ?Fluoroquinolones have offered superior bacterial killing power and breadth of coverage. Third-generation fluoroquinolones are showing increasing and outright resistance, so this next step to ZYMAR is a welcome addition.?

Price: N/A
Company: Allergan, Inc.
Phone: (714) 246-4500
Web: www.allergan.com
Key Features
• First fourth-generation fluoroquinolone FDA approved in the US
• Complete solubility
• Effective tissue penetration
• Low MIC 90s

Sovereign Compact
At last month's annual ASCRS meeting in San Francisco, Advanced Medical Optics, Inc. (Santa Ana, CA), introduced the newest member of the Sovereign phaco family, Sovereign Compact. AMO states that this new platform offers all the superior fluidics and advanced power control of the Sovereign, including the option of WhiteStar technology, on an easy-to-use, space-saving platform. Exclusive Power Matrix phacoemulsification provides a broad range of options to disassemble the nucleus quickly and efficiently while the optional WhiteStar technology allows Cold Phaco and the possibility for clearer corneas on postoperative day 1.*“Whoever said great things come in small packages was probably referring to the Sovereign Compact,” says Eric Donnenfeld, MD, of Rockville Centre, New York. “The Sovereign Compact combines responsive fluidics with the legendary energy efficiency and control of WhiteStar technology. My nurses love the ease of tubing changes and the simplicity in setting it up between cases. The compact design and surgeon control of phacoemulsification parameters makes the Sovereign Compact the ideal unit for our busy surgery center.”*Data on file AMO.

Price: N/A
Company: Advanced Medical Optics, Inc.
Phone: (714) 247-8200
Web: www.amo-inc.com
Key Features
• Console system dimensions and weight: 14” wide, 18” deep, 7.5” high, 31 lbs
• Foot pedal dimensions and weight: 6” wide, 10” deep, 5” high, 9 lbs
• I/A vacuum level: 0 to 500 mm Hg
• I/A pump flow: 0 to 50 cc/min